ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY

OPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability.

Subsidie
€ 3.276.577
2025

Projectdetails

Introduction

Treatment decisions for many pathological conditions, including inflammatory, degenerative, autoimmune, infectious diseases, and cancer, are largely based on microscopy study of the surgically excised tissue specimens (histology).

New Paradigm

OPTIPATH provides a new paradigm for gathering objective optical tissue-dependent data, which is essential to overcoming the diagnostic challenges of inter-observer variability and limited sensitivity and specificity.

Features of OPTIPATH

OPTIPATH will offer non-destructive, label-free, real-time, 3D presentation of tissue samples. This is enabled by:

  1. Revolutionary nano-photonic optical metasurfaces (OMS) for simultaneous single-shot acquisition of spectral and polarimetric information.
  2. Adaptive OMS actuated by thin-film piezoelectric Micro-Electro-Mechanical-Systems (MEMS) for rapid Vector Vortex Beam (VVB) shaping of light.
  3. Rapid confocal 3D imaging.

Data Interpretation

The wealth of objective diagnostic data provided will be interpreted using Machine Learning (ML) / Deep Learning (DL), and is essential to overcome inter-observer variability in diagnosis and provide actionable insights to the clinician.

Benefits

By utilizing optical markers present in unprepared tissue, histological procedures can be dramatically sped up, offering real-time diagnosis in operation theatres and pathology departments.

Conclusion

By offering timely and accurate diagnosis, OPTIPATH will enable early diagnosis and improved prognosis of recovery.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 3.276.577
Totale projectbegroting€ 3.276.577

Tijdlijn

Startdatum1-2-2025
Einddatum31-1-2028
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • SINTEF ASpenvoerder
  • SYDDANSK UNIVERSITET
  • OULUN YLIOPISTO
  • ASTON UNIVERSITY
  • NIL TECHNOLOGY APS
  • UNIVERSITETET I OSLO
  • OSLO UNIVERSITETSSYKEHUS HF

Land(en)

NorwayDenmarkFinlandUnited Kingdom

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

MULTIMODE NONLINEAR FIBER BASED ENDOSCOPIC IMAGING AND TREATMENT

MULTISCOPE aims to revolutionize optical diagnostics and therapy by developing a dual-function endoscopic device for real-time optical biopsy and cold atmospheric plasma treatment in gastrointestinal care.

€ 2.863.733
EIC Pathfinder

ulTRafast hOlograPHic FTIR microscopY

TROPHY combines advanced microscopy techniques to enable rapid, high-resolution imaging of tumor biopsies for precise diagnosis and tailored cancer therapies, enhancing patient outcomes.

€ 1.904.544
EIC Pathfinder

Breaking the penetration limit of microscopy – Photoswitching Optoacoustics

SWOPT aims to revolutionize in vivo imaging by combining optoacoustic imaging and photoswitching to visualize individual cells deep within tissues, enhancing research in life sciences and biomedicine.

€ 3.536.935
EIC Pathfinder

On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology

DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.

€ 3.018.312
EIC Pathfinder

Hybrid endoscope for esophageal in vivo histology and histochemistry

ESOHISTO aims to revolutionize GI cancer diagnosis through innovative endoscopic technologies that enable real-time 3D imaging of diseased tissues, enhancing early detection and treatment.

€ 3.046.127

Vergelijkbare projecten uit andere regelingen

EIC Transition

Enabling the transition to 3D digital pathology

3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally.

€ 2.493.683
ERC Proof of...

Optical imaging platform for high-throughput longitudinal studies of the eye in disease models

The OPTIMEYEZ project aims to enhance a novel multi-contrast optical imaging platform for non-invasive retinal studies, facilitating drug development in neurological diseases while reducing animal use.

€ 150.000
EIC Transition

Chemometric histopathology via coherent Raman imaging for precision medicine

The CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification.

€ 2.441.979
ERC Advanced...

In vivo Immunofluorescence-Optical Coherence Tomography

Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.

€ 2.500.000
ERC Proof of...

Live imaging module for organoids

The LiveOrg project aims to develop and disseminate a non-invasive, high-resolution imaging system for organoids to enhance quality control and therapeutic evaluation across multiple medical fields.

€ 150.000